The purpose of this study is to determine whether daily use of a lower limb venous-return assist device, "Venowave', improves leg symptoms, ability to perform activities of daily living, and quality of life in subjects with severe PTS.
Eligible consenting patients will be randomly allocated to receive either the veno-device (active or placebo for 8 weeks and crossed over for a further 8 weeks (active or placebo) following a 4 week 'wash out' period.( A randomized controlled 'crossover' study}
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
32
Henderson Research Centre
Hamilton, Ontario, Canada
Sir Mortimer B. Davis Jewish General Hospital
Montreal, Quebec, Canada
Clinical Success measured with the Global Rating Instrument
PTS-CCS questionnaire
Villalta Scale
Veines Quality of Life Questionnaire
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.